ABSTRACT Mycobacterium tuberculosis is the causal agent of tuberculosis. Tumor necrosis factor alpha (TNF-␣), transforming growth factor ␤ (TGF-␤), and gamma interferon (IFN-␥) secreted by activated macrophages and lymphocytes are considered essential to contain Mycobacterium tuberculosis infection. The CD43 sialomucin has been reported to act as a receptor for bacilli through its interaction with the chaperonin Cpn60.2, facilitating mycobacterium-macrophage contact. We report here that Cpn60.2 induces both human THP-1 cells and mouse-derived bone marrow-derived macrophages (BMMs) to produce TNF-␣ and that this production is CD43 dependent. In addition, we present evidence that the signaling pathway leading to TNF-␣ production upon interaction with Cpn60.2 requires active Src family kinases, phospholipase C-␥ (PLC-␥), phosphatidylinositol 3-kinase (PI3K), p38, and Jun N-terminal protein kinase (JNK), both in BMMs and in THP-1 cells. Our data highlight the role of CD43 and Cpn60.2 in TNF-␣ production and underscore an important role for CD43 in the host-mycobacterium interaction.
scavenger receptors; the surfactant protein (Sp-A and -D) receptors (5, 6) ; the Fc-␥ receptors (7); CD14 (8) ; the complement receptors CR1, CR3, and CR4 (9, 10); NODlike receptors; Toll-like receptor 2 (TLR2) and TLR4 (11) (12) (13) (14) (15) ; the macrophage mannose receptor (MMR) (16) ; DC-SIGN (17, 18) ; and CD43 (19, 20) . On the side of the mycobacteria, a plethora of molecules also contribute to the cell-mycobacterium interaction, such as LAM, PIMs, the 19-kDa protein (21, 22) , and the highly conserved chaperones DnaK and Cpn60.2 (23) (24) (25) .
CD43 is a heavily glycosylated and sialylated transmembrane type I protein expressed on lymphocytes, macrophages, and monocytes (26) . Two isoforms (115 kDa and 130 kDa) which express differentially branched sialic acid-rich hexasaccharides have been described for CD43 (27, 28) . This sialomucin is a multifunctional protein that participates in differentiation, proliferation, locomotion, and adhesion by activating multiple cell signaling pathways through its highly conserved intracellular domain (29) (30) (31) . Its extracellular domain has a rod-like structure that extends out of the cell membrane up to 45 nm (32) , suggesting that CD43 regulates the first contacts of a cell. A number of ligands have been reported for CD43, among which are ICAM-1, major histocompatibility complex class I (MHC-I), galectin-1, Siglec-1, nucleolin, and E-selectin (33) (34) (35) (36) (37) . CD43 has also been reported to act as a receptor for microbes and microbederived proteins (29) . In particular, Cpn60.2 and DnaK, two mycobacterial conserved chaperones belonging to the heat shock protein (HSP) family of proteins (38) , have been identified as ligands for CD43 (39) .
Similar to other pathogen-derived chaperones, Cpn60.2 and DnaK can be exported to the cell surface under stressful conditions (40) , suggesting "moonlighting" functions (41) that most likely benefit the mycobacteria. Silencing of the Cpn60.2 gene is lethal to mycobacteria, confirming that it is indispensable for mycobacterial survival (38, 42) . Cpn60.2 and Cpn60.1 are immunodominant antigens, eliciting strong immune responses in the infected host (43, 44) . Like DnaK, they induce proinflammatory or anti-inflammatory programs (45, 46) . CD43 has been reported to be a key modulator of the macrophage immune response against M. tuberculosis infection. Splenic macrophages of CD43 Ϫ/Ϫ mice bind fewer M. tuberculosis organisms than do their wild-type (WT) counterparts, showing a role for CD43 in the adhesion to and the uptake of M. tuberculosis into macrophages (19, 20) . Furthermore, in vitro, the survival and replication of M. tuberculosis are enhanced in CD43 Ϫ/Ϫ macrophages, and in vivo, the absence of CD43 leads to increased bacterial load and defective granuloma formation, suggesting that CD43-mediated signals also contribute to control of M. tuberculosis growth inside the cell (20, 47) . The facts that CD43 Ϫ/Ϫ macrophages produce less TNF-␣ in response to infection by M. avium (19) or M. tuberculosis (47) , that Cpn60.2 interacts with CD43, facilitating the adhesion of the bacterium to the cell (23, 39) , and that Cpn60.2 has been found to be a potent stimulator of leukocytes, inducing TNF-␣ production (25) , led us to investigate whether the interaction of Cpn60.2 with CD43 resulted in TNF-␣ production. We report that the interaction of Cpn60.2 with human THP-1 cells or mouse-derived bone marrow-derived macrophages (BMMs) led to TNF-␣ production in a CD43-dependent manner. In addition, we present data indicating that the signaling pathway leading to TNF-␣ in macrophages in response to Cpn60.2 involves active Src family kinases, phospholipase C-␥ (PLC-␥), phosphatidylinositol 3-kinase (PI3K), p38, and Jun N-terminal protein kinase (JNK), both in mouse-derived BMMs and in human THP-1 cells. Our data highlight the role of CD43 in TNF-␣ production in response to a BCG insult and underscore an important function for CD43 in the host response to mycobacteria.
RESULTS

Cpn60.2 binding to THP-1 cells is CD43 dependent.
The facts that CD43 Ϫ/Ϫ macrophages produce less TNF-␣ in response to M. avium (19) or M. tuberculosis (47) infection and that Cpn60.2 interacts with CD43 on the macrophage membrane (23, 39) led us to investigate whether the interaction of Cpn60.2 with CD43 resulted in TNF-␣ production. We first sought to assess whether we could reproduce the Cpn60.2-CD43 interaction previously described (39) . When lysates from phorbol myristate acetate (PMA)-differentiated THP-1 cells were incubated with Cpn60.2-loaded nickelnitrilotriacetic acid (Cpn60.2-Ni-NTA) beads or control (Ni-NTA) beads, CD43 bound to the Cpn60.2-loaded beads but not to Ni-NTA beads (Fig. 1A) , thus confirming that under our experimental conditions, both isoforms of CD43, but mainly the 130-kDa one, readily interacted with Cpn60.2. Both Cpn60.2 (Fig. 1B, panel b) and CD43 (Fig. 1B,  panel g ) were localized on the surface of PMA-differentiated THP-1 cells. Excess Cpn60.2 competed with biotin-labeled Cpn60.2 for binding to these cells (Fig. 1B , panels c and d); preincubating the cells with the anti-CD43 monoclonal antibody (MAb) L10 partially abrogated the binding of Cpn60.2 to the cell surface (Fig. 1B, panel f) , supporting the specificity of this interaction. Furthermore, Cpn60.2 and CD43 colocalized on the surface of PMA-differentiated THP-1 cells (Fig. 1C, top) and RAW-Blue cells (Fig. 1C,  bottom) . All experiments were carried out on cells that were fixed without permeabilization, ensuring that the fluorescence detected was located on the surface of the cells. The concentrations of Cpn60.2 used (0.5 g/ml [data not shown] and 1 g/ml) are consistent with data showing that these were saturating concentrations (48) . Interestingly, and consistent with data showing that PE_PGRS1 may be found at the surface of 2-His-loaded Ni-NTA beads or empty Ni-NTA beads (12 h at 4°C). The beads were then extensively washed with lysis buffer and subjected to 10% SDS-PAGE; proteins were transferred to nitrocellulose and immunoblotted with the anti-CD43 MAb L10. Data are representative of those from at least five independent experiments. (B) Differentiated THP-1 cells were incubated with streptavidin-Alexa Fluor 488 (a), His-Cpn60.2-biotin (1 g/ml) followed by streptavidinAlexa Fluor 488 (b), His-Cpn60.2-biotin (1 g/ml) and a 10-fold excess of His-Cpn60.2 followed by streptavidin-Alexa Fluor 488 (c), His-Cpn60.2-biotin (1 g/ml) and a 15-fold excess of His-Cpn60.2 followed by streptavidin-Alexa Fluor 488 (d), His-PE_PGRS1-biotin (1 g/ml) followed by streptavidinAlexa Fluor 488 (e), anti-CD43 MAb L10 (1 g/ml) (30 min for 37°C) followed by His-Cpn60.2-biotin (1 g/ml) for an additional 30 min and streptavidin-Alexa Fluor 488 (f), MAb L10 followed by Alexa Fluor 488 rabbit anti-mouse IgG (g), and Alexa Fluor 488 rabbit anti-mouse IgG The CD43-Cpn60.2 Interaction Leads to TNF-␣ Production Infection and Immunity mycobacteria and thus influence the interaction of mycobacteria with macrophages (49), we found that PE_PGRS1 protein also bound to THP-1 cells (Fig. 1B , panel e), raising the possibility that this interaction could lead to cell activation. Taken together, these data confirmed the interaction of Cpn60.2 and CD43 and showed that the two molecules colocalize on the cell surface. The Cpn60.2-CD43 interaction leads to TNF-␣ production. Cpn60.2 has been reported to induce a potent inflammatory response leading to IL-1␤ and IL-6 (50) and TNF-␣ production (38) in leukocytes. Addition of Ni-NTA beads coupled with different quantities of Cpn60.2 to BMMs resulted in the production of TNF-␣ in a dosedependent fashion, compared to findings with nonstimulated cells or Ni-NTA beadstimulated cells (Fig. 2A) . Because the amount of TNF-␣ released to the supernatant was already peaking at 10 g/ml of Cpn60.2, this concentration was used for all subsequent experiments.
To ascertain that the TNF-␣ release being measured did not reflect potential lipopolysaccharide (LPS) contamination carried throughout the purification of the recombinant proteins, Cpn60.2-coupled beads and control beads were pretreated with polymyxin B. The capacity of Cpn60.2 to promote the synthesis of TNF-␣ was not diminished in the presence of polymyxin B. In contrast, preincubation of LPS with polymixin B considerably inhibited (75%) TNF-␣ release (see Fig. S1A in the supplemental material).
To further assess whether the specific interaction of Cpn60.2 with CD43 mediated the production of TNF-␣, BMMs from WT and CD43 Ϫ/Ϫ mice were stimulated with Cpn60.2-coupled beads and the TNF-␣ concentration was measured in the culture supernatant. Whereas WT BMMs produced TNF-␣ in response to Cpn60.2, their CD43 Ϫ/Ϫ counterparts failed to do so (Fig. 2B) , suggesting that the Cpn60.2-CD43 37°C) ; the release of TNF-␣ to the culture supernatant was assessed by ELISA. Data are representative of those from at least three independent experiments. Statistical analysis was conducted with a paired t test. ***, P Յ 0.0001; **, P Յ 0.0041. NS, not significant. (B) BMMs (1 ϫ 10 5 /well) derived from C57BL/6J CD43 Ϫ/Ϫ or their heterozygote littermates were activated with Cpn60.2-or PE_PGRS1-Ni-NTA beads at 10 g/ml, Ni-NTA beads, BCG (MOI, 4:1), or LPS (500 ng/ml) for 12 h at 37°C and 5% CO 2 . Supernatants were collected and TNF-␣ was quantified by ELISA. Data are representative of those from at least three independent experiments. Statistical analysis was conducted with a paired t test. ***, P Յ 0.0001; **, P Յ 0.0048. (C) PMA-differentiated macrophages from CD43 lo THP-1 cells or mock-transfected cells (CD43 hi ) were seeded in 96-well plates (1 ϫ 10 5 /well) and challenged with the following: Cpn60.2-Ni-NTA beads, BCG (MOI, 4:1), LPS (500 ng/ml), or E. coli DH5␣ (MOI, 10:1) for 12 h at 37°C and 5% CO 2 . Supernatants were collected and TNF-␣ was quantified by ELISA. As controls, unloaded Ni-NTA beads and nonstimulated cells (US) were used in parallel. Data are representative of at least three independent experiments. Statistical analysis was conducted with a paired t test. ***, P Յ 0.0002; **, P Յ 0.0031. interaction was directly accountable for the TNF-␣ production. Stimulating the cells with PE_PGRS1, a member of the multigenic PE family of proteins, mostly restricted to pathogenic mycobacteria (51) , led also to TNF-␣ production yet in a CD43-independent manner, further supporting the notion that the TNF-␣ released to the supernatant in response to the interaction of Cpn60.2 with CD43 is specific. As has been described previously (19, 47) , the response to BCG was also significantly diminished in the CD43 Ϫ/Ϫ BMMs compared to that in WT BMMs (Fig. 2B ). In accordance with those reports, we found that WT BMMs produced significantly more IL-6 than did the CD43 Ϫ/Ϫ BMMs. Interestingly, we found that WT BMMs also produced more IL-10 ( Fig. S2) .
In evaluating whether human THP-1 cells expressing normal (CD43 hi ) or low (CD43 lo ) levels of CD43 (Fig. S1C ) produced equivalent amounts of TNF-␣ in response to Cpn60.2 stimulation, we found that the CD43 lo cells produced significantly less TNF-␣ than did CD43 hi cells. As expected, and in line with data for the CD43 Ϫ/Ϫ -derived BMMs, the response to BCG was significantly impaired in the CD43 lo cells compared to that in the CD43 hi cells (Fig. 2C) . Collectively, these data suggest that the interaction of Cpn60.2 with CD43 leads to TNF-␣ release and that under our experimental conditions, the participation of other molecules such as TLR2 and TLR4 was not significant, since WT and CD43 Ϫ/Ϫ BMMs expressed equivalent levels of macrophage-specific markers such as TLR2, TLR4, CD14, and F4/80 (Fig. S1B) . Congruent with the fact that BCG expresses a multitude of molecules that activate immune cells through multiple receptors, the concentration of TNF-␣ released by BMMs or THP-1 cells in response to BCG was higher than that detected in response to Cpn60.2-coupled beads.
The degrees of TNF-␣ production in response to LPS were comparable in WT and CD43 Ϫ/Ϫ BMMs (Fig. 2B) . Surprisingly, CD43 lo THP-1 cells were partially impaired in their capacity to release TNF-␣ in response to an LPS or E. coli (DH5␣) insult, as they released significantly less TNF-␣ than did the CD43 hi cells, although significantly more than in response to BCG (Fig. 2C) .
The fact that Cpn60.2-coupled Ni-NTA beads were actively interacting with a cell surface molecule was evidenced by the observation that the cells crawled around the large agarose beads (45-to 165-m bead size). The activity of the cells on the Cpn60.2-coated beads was clearly more intense than that of those on the control beads ( Fig. S5 and Videos S1 and S2 in the supplemental material).
Overall, these data provide evidence that the interaction between Cpn60.2 and CD43 results in TNF-␣ production both in mouse bone marrow-derived cells and in human THP-1 cells and that the lack of expression or a lower expression level of CD43 leads to a reduction in TNF-␣ production.
Signaling pathway to TNF-␣ production of Cpn60.2-challenged macrophages. As our results indicated that the release of TNF-␣ to the culture supernatant in response to a Cpn60.2 insult required the expression of the CD43 molecule, we sought to identify some of the molecules that participate in the signaling pathway to produce TNF-␣ in response to the interaction of Cpn60.2 with CD43. BMMs or differentiated THP-1 cells preincubated with specific inhibitors for proteins known to be involved in TNF-␣ production (43, 52, 53) were challenged with Cpn60.2-coupled beads as described above. TNF-␣ release was significantly inhibited in the presence of inhibitors of Src family kinases, PLC-␥, PI3K, and p38 and JNK mitogen-activated protein kinases (MAPKs), both in THP-1 cells (Fig. 3A ) and in BMMs (Fig. 3B) .
Preliminary unpublished results from our laboratory indicated that the ␣, ␤, ␥, ␦, and protein kinase C (PKC) isoforms participated in TNF-␣ production in response to BCG. In the evaluation of whether these isoforms participated in Cpn60.2-mediated TNF-␣ production, we found that in contrast to BCG stimulation (Fig. S3A ), the addition of Cpn60.2-coupled beads to Gö6983-treated BMMs resulted in augmented TNF-␣ production compared to that of cells stimulated with Cpn60.2 plus dimethyl sulfoxide (DMSO). In contrast, in human THP-1 cells, Gö6983 partially inhibited TNF-␣ production in response both to Cpn60.2-loaded beads (Fig. 3A) and to BCG (Fig. S3B) , suggesting species-specific functions for different members of the PKC family of kinases in regulating the signaling pathway for TNF-␣ production in response to different insults. The addition of DMSO, the inhibitors' vehicle, did not significantly change the amount of TNF-␣ produced. Unstimulated cells and Ni-NTA bead-stimulated cells produced background levels of TNF-␣. Consistent with these data, the phosphorylation of the specific targets downstream of the inhibited kinase was diminished, as determined by immunoblotting on BMMs activated with BCG (Fig. S4) .
Thus, challenging mouse BMMs or human THP-1 cells with BCG involved a common set of signaling molecules that includes the Src family kinases, PLC-␥, PI3K, and the MAPKs JNK and p38. Interestingly, some species-specific differences in terms of PKC and ERK1/2 participation were observed.
NF-B and AP-1 are activated by Cpn60.2 to produce TNF-␣. The promoter region of the gene that encodes TNF-␣ has sites for NF-B and AP-1, among other transcription factors, all of which are activated by BCG or M. tuberculosis (54) . When assessing the recruitment of NF-B and AP-1 in response to Cpn60.2 stimulation in RAW-Blue cells, a TLR2 ϩ TLR4 ϩ CD43 ϩ murine macrophage line (Fig. 4A ) that expresses an inducible secreted embryonic alkaline phosphatase (SEAP) reporter gene under the control of NF-B and AP-1, we found that when challenged with increasing amounts of Cpn60.2, cells released increasing amounts of SEAP, which reached a plateau at 10 g/ml (Fig. 4B) , indicating that the activation of NF-B and AP-1 was dose dependent. Stimulation with BCG induced greater amounts of SEAP (Fig. 4B) , reflecting the antigenic complexity of BCG and the subsequent activation of multiple signaling pathways converging on these transcription factors.
To unravel the signaling pathway leading to NF-B and AP-1 activation in response to Cpn60.2 stimulation, RAW-Blue cells were preincubated with specific inhibitors of Src family kinases, PLC-␥, PI3K, PKC, MEK 1/2, p38, JNK, and NF-B (Fig. 4C) . Consistent with data shown in Fig. 3 , all inhibitors significantly prevented SEAP release, indicating the activation of NF-B resulting from stimulation of the cells with Cpn60.2-coupled beads. Although inhibiting the ␣, ␤, ␥, ␦, and PKC isoforms did not interfere with TNF-␣ production in mouse BMMs, Gö6983 inhibited the activation of the AP-1 and NF-B transcription factors in the mouse-derived RAW-Blue cells, although to a lesser extent than the Src, PLC-␥, PI3K, MEK 1/2, p38, JNK, and NF-B inhibitors, suggesting that these PKC isoforms are dispensable for AP-1 or NF-B activation.
The data suggested that the MAPKs, which can control NF-B recruitment (55), played a central role in the signaling pathway for TNF-␣ production in response to PMA-differentiated THP-1 macrophages (A) or BMMs (B) were seeded into 96-well plates (1 ϫ 10 5 cells/well) and incubated in presence or absence of selective inhibitors of PLC-␥, PI3K, MAPKs (p38, ERK, and JNK), and PKC for 1 h prior to challenge with Cpn60.2 (10 g/ml) for 12 h at 37°C and 5% CO 2 . Supernatants were collected and the amount of TNF-␣ was measured by ELISA. Data from three independent experiments, each done in triplicate, are shown. Data are shown as fold increase compared to value obtained with Ni-NTA beads. Statistical analysis was conducted with a paired t test. ***, P Յ 0.0007; **, P Յ 0.081; *, P Յ 0.0488.
Cpn60.2 and that Cpn60.2 stimulation resulted in NF-B recruitment. Consistent with this, the NF-B inhibitor BAY117082 suppressed TNF-␣ production in WT BMMs (Fig.  4D ) and THP-1 cells (Fig. 4E ) in response to Cpn60.2-loaded beads, BCG, or LPS. Thus, despite the fact that the TNF-␣ promoter has sites for ATF-2, Sp1, NFAT, and AP-1, among others, the results showed that NF-B was crucial to produce this cytokine in response to Cpn60.2.
DISCUSSION
Whereas for most pathogens the recruitment of professional phagocytic cells is sufficient to restrict and eliminate the pathogen, in the case of M. tuberculosis, their arrival to the lungs, particularly that of macrophages, benefits the pathogen by providing additional niches for bacterial expansion. During the evolution of M. tuber- , Ni-NTA beads, BCG (ratio of bacteria to cells, 4:1), or LPS (500 ng/ml) for 12 h at 37°C and 5% CO 2 . SEAP activity was measured in the supernatant to assess NF-B or AP-1 activation. (D) BMMs from 4-to 6-week-old male C57BL/6 WT mice were seeded into 96-well plates (1 ϫ 10 5 cells/well) and incubated in the presence or absence of the NF-B inhibitor BAY117082 1 h prior to challenge with Cpn60.2-coupled beads (10 g/ml), Ni-NTA beads, BCG (ratio of bacteria to cells, 4:1), or LPS (500 ng/ml) for 12 h at 37°C and 5% CO 2 . The supernatant was collected and TNF-␣ was measured by ELISA. (E) PMA-differentiated THP-1 cells were seeded into 96-well plates (1 ϫ 10 5 cells/well) and incubated in the presence or absence of the NF-B inhibitor BAY117082 1 h prior to challenge with Cpn60.2-loaded Ni-NTA beads (10 g/ml), NTA-nickel beads, BCG (ratio of bacteria to cells, 4:1), or LPS (500 ng/ml) for 12 h at 37°C and 5% CO 2 . The supernatant was collected and TNF-␣ was measured by ELISA. For all graphs, data represent those from three independent experiments each done in triplicate. Data are shown as fold increase compared to value obtained with Ni-NTA beads. Statistical analysis was conducted with a paired t test. ***, P Յ 0.0007; *, P Յ 0.0488.
The CD43-Cpn60.2 Interaction Leads to TNF-␣ Production
Infection and Immunity culosis infection, TNF-␣ mediates several functions: it induces the expression of chemokines that potentiate the recruitment of new uninfected macrophages from vascular sources, it controls the caspase-mediated apoptosis of infected cells and IL-10 synthesis, and it is critical for the granuloma formation, with removal or lack of TNF-␣ resulting in unstructured granulomas and a large increase in total bacterial burden (56) . Interestingly, mice deficient in the CD43 molecule, a receptor for the M. tuberculosis chaperone Cpn60.2, develop unstructured granulomas and have a large increase in bacterial burden (20) . Consistent with data describing CD43 as a molecule that significantly contributes to TNF-␣ production and growth inhibition of M. tuberculosis in macrophages (19, 20, 47) , a recent report indicates that CD43 polymorphisms are associated with susceptibility to tuberculosis disease manifestations and worst outcomes (57) . The fact that survival and replication of M. tuberculosis were significantly enhanced in CD43-deficient mice suggests that in addition to serving as an adhesion molecule that facilitates the uptake of the mycobacteria, CD43 participates in subsequent events within the macrophages (20) , contributing to and shaping the outcome of the infection. In this study, we focused on the outcome of the interaction between CD43 and the mycobacterial chaperonin Cpn60.2. This molecule has been reported to induce human monocytic cells to release proinflammatory cytokines (44) and to interact with TLR2 and TLR4. However, despite the fact that the Myd88-dependent pathway is the most common pathway for cell activation following TLR engagement, Cpn60.2 minimally uses this pathway for TNF-␣ production (38) , suggesting the participation of other macrophage surface molecules such as CD43.
To evaluate the possibility that the interaction between CD43 and Cpn60.2 in macrophages resulted in TNF-␣ production, we confirmed the interaction of CD43 with recombinant Cpn60.2. Furthermore, we showed that Cpn60.2 and CD43 colocalized on the surface of PMA-differentiated THP-1 cells and on that of RAW-Blue cells, that excess Cpn60.2 competed, in a dose-dependent manner, with biotin-labeled Cpn60.2 for interaction with THP-1 cells, and that preincubating the cells with Cpn60.2 reduced the amount of anti-CD43 MAb binding to the cells. The experimental conditions used in the microscopy experiments suggested that CD43-Cpn60.2 interaction was stronger at 37°C than at room temperature (data not shown). All together, these data support the interaction of Cpn60.2 and CD43.
The experiments with BMMs from WT and CD43-deficient mice suggest that CD43 is responsible for TNF-␣ production and that under the experimental conditions used in this study, the participation of other molecules such as TLR2 and TLR4 (two other counterreceptors for Cpn60.2) was not significant, as all cells expressed equivalent amounts of macrophage markers such as TLR2, TLR4, CD14, and F4/80. However, whether Cpn60.2 competes with other CD43 ligands and whether the Cpn60.2 that binds to THP-1 cells following incubation of the cells with anti-CD43 MAb interacts with TLR2 and TLR4 remain to be investigated.
Stimulating the mouse-derived BMMs with LPS or a control His-tagged mycobacterial protein (His-PE_PGRS1) induced equivalent amounts of TNF-␣ independent of CD43 expression level, supporting the notions that the interaction of Cpn60.2 with CD43 specifically leads to TNF-␣ production and that the inability of CD43-deficient cells to produce TNF-␣ in response to Cpn60.2 stimulation did not reflect potential defects in the signaling pathway to produce TNF-␣. Likewise, interfering with the expression level of CD43 in human THP-1 cells significantly decreased the amount of TNF-␣ released to the supernatant in response to Cpn60.2 compared to the amount with cells expressing normal levels of CD43.
In addition, and as previously reported (19, 47) , we found that WT BMMs produced significantly more IL-6 than did the CD43 Ϫ/Ϫ BMMs. However, contrary to those reports and despite the fact that in the present experiments, the cells were stimulated for only 12 h, we found that WT BMMs also released more IL-10 into the supernatant; this discrepancy is possibly a result of the lower sensitivity of the enzyme-linked immunosorbent assay (ELISA) used by Randhawa et al. (47) .
Interestingly, we found that in addition to impairing TNF-␣ production in response to Cpn60.2 and BCG, lowering the expression level of CD43 in THP-1 cells (CD43 lo cells) resulted also in a lower response to LPS and to E. coli DH5␣ bacterial insults compared to that of cells expressing normal levels of CD43. Although previous reports (19, 20) indicate that in the CD43 Ϫ/Ϫ model, CD43 participates in the binding of BMMs to M. tuberculosis and to M. avium but not in that of other bacteria such as Salmonella enterica serovar Typhimurium or Listeria monocytogenes, the capacity to produce TNF-␣ was not evaluated. Whether the present results reflect a previously unknown role of CD43 in regulating pathogen-associated molecular pattern (PAMP) receptors remains to be determined.
In addition and consistent with the fact that PE_PGRS1 elicits TNF-␣ release from macrophages in a TLR2-dependent manner (58), the results obtained in this study with PE_PGRS1 substantiate the importance of the PE_PGRS subfamily of proteins in the host-mycobacterium interaction.
Mycobacterium tuberculosis exposes a plethora of lipoproteins, virulence factors, and moonlighting proteins that interact with different macrophage receptors, thus stimulating signaling pathways to proinflammatory and anti-inflammatory pathways. Members of the MAPK and PKC families as well as PI3K are activated during that process of recognition (54, 59, 60) . The signaling pathway leading to TNF-␣ in macrophages in response to Cpn60.2 required active PLC-␥, PI3K, p38, and JNK, both in mouse-derived BMMs and in human THP-1 cells. Regarding the participation of members of the PKC family, our results indicate that inhibiting the ␣, ␤, ␥, ␦, and PKC isoforms has different effects depending on the host species. In BMMs, inhibition of those isoforms results in enhanced TNF-␣ production in response to Cpn60.2, suggesting that inhibiting those isoforms negatively controls some regulatory signaling circuits. In the human cells, inhibiting those isoforms inhibited TNF-␣ production, suggesting that PKC-␣, -␤, -␥, -␦, and -participate in the signaling pathway to produce TNF-␣. Overall, these data are consistent with other reports describing the signaling pathway to TNF-␣ in macrophages stimulated with live pathogenic or nonpathogenic strains of M. tuberculosis, BCG, LPS, or Man-LAM (59, 60) , and these data do not disagree with the signaling pathways being triggered through CD43 (29) . Moreover, preliminary data from our laboratory indicates that cross-linking CD43 on THP-1 cells induced TNF-␣ production through a signaling pathway that requires PLC-␥, PI3K, Src family kinases, and JNK and p38 MAPKs. Whether the TNF-␣ produced as a result of the CD43-Cpn60.2 interaction requires the participation of different members of the PKC family than that produced by stimulating the cells with BCG remains to be elucidated.
MAPKs occupy a central position in all models devoted to the study of macrophage signaling in response to mycobacteria. Particularly, JNK and p38 participate in stress responses by favoring the production of inflammatory cytokines and regulating the transcription of Cox2 and NOS2 (61, 62) , by activating different transcription factors (63) , among which are AP-1 and NF-B. The experiments with the SEAP reporter gene confirm the contribution of JNK and p38 to activation of these two transcription factors in response to the Cpn60.2 stimulus. Furthermore, we show that the Cpn60.2-dependent release of TNF-␣ by WT BMMs is totally abolished in the presence of the NF-B inhibitor.
Taken together, the data presented here indicate that the interaction between the CD43 sialomucin and the M. tuberculosis chaperonin Cpn60.2 activated a signaling pathway that results in TNF-␣ production by macrophages. Our results underscore the need to gain a deeper understanding of the molecular mechanisms that allow mycobacteria to achieve the colonization of macrophages. Through such advances in this understanding, it may be possible to identify molecular targets that will lead to design of therapies able to hinder the survival of the mycobacteria.
MATERIALS AND METHODS
Reagents. Commercially available BCG (Tokyo strain 172), sold in Mexico under the name TUVAX, was obtained from Japan BCG Laboratory. PMA was obtained from Calbiochem, and LPS L4516 was purchased from Sigma-Aldrich. The inhibitors U73122, LY290012, SB202190, SP600125, and Gö6983 were from Calbiochem; BAY117082 was purchased from Santa Cruz Biotechnology. All inhibitors were disThe CD43-Cpn60.2 Interaction Leads to TNF-␣ Production Infection and Immunity solved in tissue culture-grade DMSO. Polymyxin B was obtained from Sigma-Aldrich. Anti-CD43 DFT-1 was obtained from Ancel; the anti-CD43 MAb L10 was purified from mouse ascites; anti-TLR2, -TLR4, and -CD14 were from eBiosciences; and F4/80 was from Abcam. Ni-NTA agarose beads were purchased from Qiagen. Cloning, expression, and purification of M. tuberculosis Cnp60.2 and PE_PGRS1. The coding regions of the cnp60.2 and pe-pgrs1 genes were amplified by PCR with the high-fidelity DNA polymerase Pfx (Invitrogen) from M. tuberculosis H37Rv genomic DNA and the following oligonucleotide primers: cnp60.2 Fo, 5=-GCCATATGGCCAGAAATGCGTAC-3= (NdeI site in bold); cnp60.2 Rv, 5=-CGTCGACGAAAT CCATGCCACCCA-3= (SalI site in bold); pe-pgrs1 Fo, 5=-GGACATATGTCGCTTTTGATCACATCACCG-3= (NdeI site in bold); and pe-pgrs Rv, 5=-CCTAGCTCGGCCCGGGGG-3=. PCR products were ligated into the pCR4 Blunt-TOPO vector (Invitrogen). The NdeI-SalI cnp60.2 fragment was cloned into the pET22b plasmid and the pe-pgrs1 NdeI-BamHI fragment into the pET15b vector. The identities of the inserts were confirmed by restriction analysis and DNA sequencing. E. coli strain Rosetta (DE3) (Novagen) was transformed with pET22b-cnp60.2 or pET15b-pe-pgrs1. Heterologous expression of the Cpn60.2 and PE_PGRS1 proteins was induced in logarithmic-phase cultures with 0.25 mM isopropyl-␤-D-thiogalactopyranoside (IPTG). After induction (3 h), bacteria were harvested and washed with cold phosphate-buffered saline (PBS). The bacterial pellets were resuspended in 20 mM Tris-HCl, 50 mM NaCl (pH 8.0), and PBS (3 ml/g [wet weight]), sonicated, and centrifuged (24,000 ϫ g, 20 min, and 4°C). The recombinant Cnp60.2 was found in the supernatant as a soluble protein, whereas PE_PGRS1 was present in inclusion bodies. The PE_PGRS1 pellet was washed twice with 2% Triton X-100 in PBS and once with PBS, and inclusion bodies were solubilized in buffer (20 mM Tris-HCl, 50 mM NaCl, 8 M urea [pH 7.5]) with stirring (overnight at 4°C). The suspension was clarified by centrifugation (24,000 ϫ g, 15 min, and 4°C). Recombinant proteins were purified with an AKTA fast-performance liquid chromatography (FPLC) system (GE Healthcare) with a 1-ml HiTrap chelating column (Pharmacia) previously equilibrated with 20 mM Tris-HCl, 50 mM NaCl, and 20 mM imidazole (pH 8.0). Proteins were eluted by using a gradient (0 to 100%) elution buffer (20 mM Tris-HCl, 50 mM NaCl, 500 mM imidazole [pH 7.5]). Fractions containing the recombinant Cnp60.2 were pooled and dialyzed against 50 mM NaCl and 20 mM Tris-HCl (pH 7.5). The recombinant PE_PGRS1 was dialyzed against the same buffer but with decreasing urea concentrations. Proteins were quantified by the modified Lowry method and stored at Ϫ70°C until needed. Prior to addition of the proteins to the cells, the His-tagged Cpn60.2 or PE_PGRS1 was bound to Ni-NTA agarose beads (Qiagen) by following the manufacturer's recommendations. To ensure that samples were devoid of LPS, the beads were routinely incubated (1 h at 37°C) with polymyxin B (33 g/ml) under agitation and then extensively washed with sterile PBS and RPMI 1640 prior to cell activation.
Mice. CD43 Ϫ/Ϫ mice (F2 C57BL/6J ϫ 129S1/SvImJ) were purchased from Jackson Laboratories and backcrossed for nine generations on a C57BL/6J background. CD43 Ϫ/Ϫ mice and wild-type (CD43 ϩ/ϩ [WT]) mice were housed in a specific-pathogen-free animal facility, in microisolator cages with food and water ad libitum. For all experiments, 6-to 12-week-old male mice were used; controls were littermates. This study was approved by the Bioethics Committee of the Instituto de Biotecnología, Universidad Nacional Autónoma de México; experiments were carried out according to institutional guidelines.
Cells. Human THP-1 cells, a monocytic cell line, were grown in RPMI medium (Invitrogen) supplemented with 10% fetal calf serum (FCS; Invitrogen), penicillin (100 U/ml)-streptomycin (100 g/ml) (Sigma-Aldrich), and 2 mM glutamine (Invitrogen), referred to here as culture medium. To obtain bone marrow-derived macrophages (BMMs), C57BL/6 WT or CD43 Ϫ/Ϫ mice were killed by cervical dislocation, femurs and tibias were dissected free of adherent tissue, the ends of the bones were then cut off, and the marrow tissue was flushed with a syringe filled with culture medium. The cells were dispersed by passing them through a 25-gauge needle and by vigorous pipetting. After a washing, 3 ϫ 10 6 to 5 ϫ 10 6 cells were seeded onto bacteriological petri dishes in 10 ml of Dulbecco modified Eagle medium (DMEM) containing 10% fetal bovine serum (FBS) and 10% L929 cell culture supernatant as a source of macrophage colony-stimulating factor. Once macrophages were 80% confluent (day 7), they were detached with PBS-EDTA and seeded as needed for each experiment. RAW-Blue cells (InvivoGen) were grown according to the manufacturer's instructions. All cells were cultured at 37°C and 5% CO 2 .
Transfections. A synthetic oligonucleotide coding for an interfering RNA (RNAi) specific for the human CD43 mRNA (AA ATG GCC ACG CTT CTC CT) was cloned into the BglII-Sal1 sites of the pSuper/EGFP plasmid (64, 65) . THP-1 cells were transfected with DraIII-linearized DNA (0.5 g) with an AMAXA Nucleofector (Lonza) with the V-01 program and subjected to clonal selection in the presence of G418 (900 g/ml). GFP ϩ , G418-resistant clones were checked for the expression level of CD43 by flow cytometry. The efficiency of this process was low (20 to 30% of the G418 resistant clones were GFP ϩ and out of those, 60 to 70% clones expressed lower levels of CD43 [CD43 lo ] than did GFP ϩ pSuper clones [CD43 hi ]). Thus, to ensure that we had selected clones that would remain CD43 lo (RNAi) or CD43 hi (transfected with the empty vector) once differentiated, GFP ϩ CD43 lo and GFP ϩ CD43 hi pSuper clones were submitted to a second round of selection based on their ability to differentiate into macrophagelike cells when cultured in the presence of PMA (50 ng/ml for 96 h) and to secrete TNF-␣ in response to a BCG stimulus. GFP ϩ THP-1 cells were cultured at 1 ϫ 10 5 to 3 ϫ 10 5 cells/ml. Cellular activation. BMMs from either WT or CD43 Ϫ/Ϫ C57BL/6 mice and PMA-differentiated (50 ng/ml for 96 h) WT, CD43 lo , or CD43 hi THP-1 cells were seeded in culture medium at 1 ϫ 10 5 per well in 96-well plates and incubated overnight at 37°C and 5% CO 2 . After nonadherent cells were carefully removed by aspiration, cells were arrested overnight in serum-free DMEM (BMMs) or RPMI medium (THP-1 cells) prior to activation (12 h at 37°C and 5% CO 2 ) with either BCG (multiplicity of infection [MOI], 4:1), LPS (500 ng/ml), Ni-NTA-Cpn60.2 beads, Ni-NTA-PE_PGRS1 beads, or Ni-NTA beads. The Ni-NTA agarose beads (45-to 165-m bead size) were loaded with the desired amounts of recombinant His-tagged protein per milliliter of beads. Where indicated, cells were incubated with specific inhibitors of PLC-␥ (U73122; 2 M); PI3K (LY290012; 40 M); p38 MAPK (SB202190; 10 M); JNK (SP600125; 12 M); MEK 1/2 (PD98059; 25 M); PKC-␣, -␤, -␥, -␦, and -(Gö6983; 4 M); and NF-B (BAY117082; 10 M) for 1 h before activation. As a control to assess the effect of a vehicle, cells were incubated in DMSO alone. At the end of the activation period, supernatants were carefully removed and frozen until processed for TNF-␣ determination.
Cytokine quantification. TNF-␣ released to supernatants was quantified by ELISA according to the manufacturer's protocol (TNF-␣ ELISA Ready-SET-Go!; eBioscience). Alternatively, IL-6, IL-10, and TNF-␣ were quantified with a bead-based immunoassay (LEGENDplex; BioLegend). Cytokine levels were measured 12 h after the onset of the experiment.
Pulldown . Cells (1 ϫ 10 6 ) were lysed with 100 l of lysis buffer (10 min at 4°C); lysates were centrifuged (14,000 ϫ g, 15 min, and 4°C) and kept at Ϫ70°C until use. For pulldown experiments, cellular lysates (300 g) were incubated with Cpn60.2 (200 g/ml)-NTA beads or Ni-NTA beads and agitated overnight (4°C); thereafter, the beads were washed three times with PBS and boiled with SDS-PAGE sample buffer. SDS-PAGEresolved proteins were transferred to nitrocellulose, and immunoblotting was performed as previously described (66) . Immunoreactive bands were visualized using a chemiluminescent substrate, ECL Plus (Perkin-Elmer), according to the manufacturer's instructions.
Quanti-Blue assays. After RAW-Blue cells (1 ϫ 10 5 /well), which stably express a secreted embryonic alkaline phosphatase (SEAP) gene inducible by the NF-B and AP-1 transcription factors (InvivoGen), had been preincubated with or without inhibitors as described under "Cellular activation" above, they were stimulated with Cpn60.2 or BCG for 12 h (37°C and 5% CO 2 ). Supernatants were collected, and secreted embryonic alkaline phosphatase activity was measured by using a colorimetric assay based on the changes of the Quanti-Blue dye from pink to blue, as indicated by the manufacturer (InvivoGen).
Cytometry. Cells were stained with antibodies against F4/80, CD14, TLR2, TLR4, and/or CD43 as described previously (67) . In order to prevent the nonspecific binding of antibodies to Fc receptors, cells were preincubated with 10% serum (human or murine, as appropriate). Cells were analyzed with a FACSCanto II cytometer (Becton Dickinson) and FlowJo software (Tree Star, Inc.).
Microscopy. THP-1 or RAW-Blue cells (5 ϫ 10 5 ) were seeded in FluoroDish cell culture dishes (World Precision Instruments) and differentiated with PMA (50 ng/ml) for 96 h at 37°C and 5% CO 2 . After removal of nonadherent cells, the adherent cells were arrested for 12 h in serum-free RPMI medium (THP-1) or DMEM (RAW-Blue). The cells were then gently washed with prewarmed PBS before addition of biotinlabeled (ECL protein biotinylation module/system; Amersham) Cpn60.2 or PE_PGRS1 (1 g/ml) and further incubated for 30 min at 37°C and 5% CO 2 . Excess proteins were removed with warm PBS (3 washes) prior to incubation with Alexa Fluor 488-streptavidin (2 g/ml; Molecular Probes) for 30 min at 37°C and 5% CO 2 . To visualize the CD43 molecule, cells were incubated as indicated with the anti-CD43 MAb DFT-1-PE (1 g/ml; BioLegend) or with the MAb L10 (1 g/ml; 30 min) followed by an Alexa Fluor 488 secondary antibody (1 g/ml; Southern Biotech). For colocalization assays, cells were incubated with Cpn60.2 followed by Alexa Fluor 488-streptavidin at 37°C, washed to remove excess reagents, fixed with 2% paraformaldehyde (PFA) in PBS (10 min at room temperature), and then stained for CD43 with the MAb DFT-1-PE; no permeabilization steps were included in the process. Pictures were taken with an Olympus IX-81 MOT inverted microscope with a CoolLED PE2 epifluorescence system, using a 63ϫ differential interference contrast (DIC) water objective and a CoolSNAP HQ monochrome chargecoupled-device (CCD) camera (Photometrics); alternatively, confocal images were taken with a 60ϫ objective (numerical aperture, 1.3) on an Olympus FV1000 confocal microscope equipped with 488-nm and 533-nm lasers. Images were obtained using Micro-Manager open-source microscopy software (v1.4) (https://micro-manager.org/) and processed with ImageJ (https://imagej.nih.gov/ij/) and AdobePhotoshop. For the time-lapse videos, culture dishes were set in a prewarmed environmental chamber, and images were recorded every minute for at least 1 h. The cells were maintained in RPMI medium during the assay. The videos were edited with ImageJ and exported in .avi.
E. coli DH5␣ heat inactivation. DH5␣ bacteria were grown in LB medium at 37°C until the culture reached an optical density at 600 nm of 0.6; bacteria were then heat inactivated (30 min for 66°C) and stored at Ϫ70°C until used.
Statistical analysis. Data shown are the means Ϯ standard deviations (SDs) from three independent experiments, each run in triplicate. Data were analyzed with a paired t test using GraphPad Prism version 5 for Windows. Differences were considered statistically significant at a P value of Յ0.05.
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